Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Solid Tumors × Antiemetics × Clear all

Sponsor

Conditions

Multiple Myeloma 2 Lymphoma 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

tislelizumab 4 talazoparib 4 pembrolizumab 4 Docetaxel 4 Nivolumab 3 PM 01183 2 MLN 8237 2 Itraconazole 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 utomilumab 1 urelumab 1 ulixertinib 1 trifluridine tipiracil drug combination 1 sitravatinib 1 sapanisertib 1 pexidartinib 1 pevonedistat 1 peposertib 1 niraparib 1 mogamulizumab 1 lenvatinib 1 ixabepilone 1 eribulin 1 durvalumab 1 dalotuzumab 1 avelumab 1 ascrinvacumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡